Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Pulm Pharmacol Ther. 2009 Apr;22(2):71-4. doi: 10.1016/j.pupt.2008.12.019. Epub 2008 Dec 31.

    TRPA1: a potential target for anti-tussive therapy.

    Source

    Division of Allergy and Clinical Immunology, Johns Hopkins Medical Institutions, Baltimore, MD 21224, USA.

    Abstract

    Cough occurs as a result of the activation of specific airway sensory nerves. The mechanisms by which tussive stimuli activate these sensory nerves are starting to be understood and suggest that TRPA1 channels are heavily involved. TRPA1 channels are nociceptor-specific ion channels that are gated by a wide range of exogenous irritants and endogenously-produced inflammatory mediators, suggesting that the blockade of TRPA1 represents a novel therapy for the treatment of cough in humans.

    PMID:
    19150409
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk